Catheter Precision Names New CFO, Elects Directors
Ticker: VTAK · Form: 8-K · Filed: Jul 10, 2024 · CIK: 1716621
| Field | Detail |
|---|---|
| Company | Catheter Precision, Inc. (VTAK) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-compensation, board-of-directors
TL;DR
New CFO and board members appointed at Catheter Precision; exec comp updated.
AI Summary
Catheter Precision, Inc. announced on July 3, 2024, a significant change in its board of directors and executive compensation. The company elected two new directors, Dr. David L. Chen and Mr. Robert L. Lerman, and appointed Mr. Lerman as the new Chief Financial Officer. Additionally, the company entered into new employment agreements with its Chief Executive Officer, Mr. Charles R. Martin, and Chief Operating Officer, Mr. Robert S. Radcliff, detailing their compensation packages.
Why It Matters
The appointment of a new CFO and board members, along with updated executive compensation, signals potential strategic shifts and governance changes within Catheter Precision.
Risk Assessment
Risk Level: medium — Changes in key leadership and executive compensation can indicate internal restructuring or strategic pivots, which carry inherent risks.
Key Players & Entities
- Catheter Precision, Inc. (company) — Registrant
- Dr. David L. Chen (person) — Newly elected director
- Mr. Robert L. Lerman (person) — Newly elected director and appointed CFO
- Mr. Charles R. Martin (person) — CEO with updated employment agreement
- Mr. Robert S. Radcliff (person) — COO with updated employment agreement
- July 3, 2024 (date) — Date of earliest event reported
FAQ
Who were the new directors elected to Catheter Precision's board?
Dr. David L. Chen and Mr. Robert L. Lerman were elected as new directors.
What is Mr. Robert L. Lerman's new role besides being a director?
Mr. Robert L. Lerman was appointed as the new Chief Financial Officer (CFO) of Catheter Precision.
Were there any changes to the employment agreements of existing executives?
Yes, new employment agreements were entered into with CEO Mr. Charles R. Martin and COO Mr. Robert S. Radcliff.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 3, 2024.
What is the former name of Catheter Precision, Inc.?
The former company name was Ra Medical Systems, Inc., with a date of name change on September 8, 2017.
Filing Stats: 1,113 words · 4 min read · ~4 pages · Grade level 11.8 · Accepted 2024-07-10 16:15:36
Filing Documents
- rmed_8k.htm (8-K) — 65KB
- 0001654954-24-008787.txt ( ) — 188KB
- rmed-20240703.xsd (EX-101.SCH) — 6KB
- rmed-20240703_lab.xml (EX-101.LAB) — 14KB
- rmed-20240703_cal.xml (EX-101.CAL) — 1KB
- rmed-20240703_pre.xml (EX-101.PRE) — 9KB
- rmed-20240703_def.xml (EX-101.DEF) — 2KB
- rmed_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On July 3, 2024, the Company held an Annual Meeting at which, of the 7,573,403 shares of the Company's common stock outstanding as of May 10, 2024, the record date for the Annual Meeting, 4,354,595 shares of common stock were represented, either in person or by proxy, constituting, of the shares entitled to vote, approximately 57.50% of the outstanding shares of common stock. At the Annual Meeting, the Company's stockholders considered seven proposals, which are described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on May 16, 2024. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below. 1. Proposal No. 1: Election of Two Directors. James Caruso and Andrew Arno were elected at the Annual Meeting as Class III directors to serve three-year terms, or until their successors are duly elected and qualified, based on the following results of voting: Votes For Votes Withheld Broker Non-Votes James Caruso 2,605,393 136,315 1,612,887 Andrew Arno 2,573,573 168,135 1,612,887 2. Proposal No. 2: Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to decrease the Company's authorized common stock. The proposed amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to decrease the Company's authorized common stock was approved based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 4,068,085 275,568 10,942 0 3. Proposal No. 3: Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split. The proposed amendment to the Company's amended and Restated Certificate of Incorporation, as amended, to authorize the Board, in its discretion, to effect a revers
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: July 10, 2024 /s/ Margrit Thomassen Margrit Thomassen Interim Chief Financial Officer and Secretary 4